APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomedical Materials

Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.

Selected research

Market Outlook & Growth Opportunities

Global Biomedical Materials Market Outlook and Growth Opportunities 2026

28 December 2025195 pages

Choose your research edition.

Industry ResearchBiomedical Materials Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomedical Materials Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Biomedical Materials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomedical Materials Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomedical Materials Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Biomedical materials are materials used to diagnose, treat, repair or replace damaged tissues and organs or enhance their functions in organisms. It is closely related to the study of artificial organs and medical devices, and has become an important branch of contemporary materials science. Especially with the vigorous development and major breakthroughs of biotechnology, biomedical materials have become a hot spot for scientists from all over the world to conduct research and development.

Global Biomedical Materials key players include Johnson & Johnson, ZimmerBiomet, Medtronic, Abbott Laboratories, etc. Global top four manufacturers hold a share about 30%.

North America is the largest market, with a share over 55%, followed by Europe, and Rest of Asia, both have a share over 25 percent.

Read the full market overview

In terms of product, Plastic Surgery is the largest segment, with a share over 20%. And in terms of application, the largest application is Treatment, followed by Health and Beauty.

This report provides an overview of the global Biomedical Materials market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomedical Materials and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomedical Materials revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biomedical Materials market.

Biomedical Materials Segment by Company

Johnson & Johnson

ZimmerBiomet

Medtronic

Abbott Laboratories

Stryker

Boston Scientific

Smith+Nephew

B-Braun

Straumann

Danaher Corporation

Dentsply Sirona

Cook Medical

Terumo

MicroPort

Lepu Medical

Biomedical Materials Segment by Type

Orthopaedic

Cardiac Surgery

Neurosurgery

Plastic Surgery

Other

Biomedical Materials Segment by Application

Treatment

Health and Beauty

Biomedical Materials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biomedical Materials status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biomedical Materials key companies, revenue, market share, and recent developments.

3. To split the Biomedical Materials breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biomedical Materials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biomedical Materials significant trends, drivers, influence factors in global and regions.

6. To analyze Biomedical Materials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Materials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical Materials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Materials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomedical Materials industry.

Chapter 3: Detailed analysis of Biomedical Materials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biomedical Materials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biomedical Materials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biomedical Materials Industry Trends Table 2. Biomedical Materials Industry Drivers Table 3. Biomedical Materials Industry Opportunities and Challenges Table 4. Biomedical Materials Industry Restraints Table 5. Global Biomedical Materials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biomedical Materials Revenue Share by Company (2021-2026) Table 7. Global Biomedical Materials Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biomedical Materials Key Company Manufacturing Base & Headquarters Table 9. Global Biomedical Materials Company, Product Type & Application Table 10. Global Biomedical Materials Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biomedical Materials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Orthopaedic Table 15. Significant Companies of Cardiac Surgery Table 16. Significant Companies of Neurosurgery Table 17. Significant Companies of Plastic Surgery Table 18. Significant Companies of Other Table 19. Global Biomedical Materials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Biomedical Materials Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Biomedical Materials Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Biomedical Materials Sales Value Share by Type (2021-2026) Table 23. Global Biomedical Materials Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Treatment Table 25. Significant Companies of Health and Beauty Table 26. Global Biomedical Materials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Biomedical Materials Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Biomedical Materials Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Biomedical Materials Sales Value Share by Application (2021-2026) Table 30. Global Biomedical Materials Sales Value Share by Application (2027-2032) Table 31. Global Biomedical Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Biomedical Materials Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Biomedical Materials Sales Value Share by Region (2021-2026) Table 34. Global Biomedical Materials Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Biomedical Materials Sales Value Share by Region (2027-2032) Table 36. Global Biomedical Materials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Biomedical Materials Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Biomedical Materials Sales Value Market Share by Country (2021-2026) Table 39. Global Biomedical Materials Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Biomedical Materials Sales Value Market Share by Country (2027-2032) Table 41. Johnson & Johnson Company Information Table 42. Johnson & Johnson Business Overview Table 43. Johnson & Johnson Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Johnson & Johnson Biomedical Materials Product Portfolio Table 45. Johnson & Johnson Recent Development Table 46. ZimmerBiomet Company Information Table 47. ZimmerBiomet Business Overview Table 48. ZimmerBiomet Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. ZimmerBiomet Biomedical Materials Product Portfolio Table 50. ZimmerBiomet Recent Development Table 51. Medtronic Company Information Table 52. Medtronic Business Overview Table 53. Medtronic Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Medtronic Biomedical Materials Product Portfolio Table 55. Medtronic Recent Development Table 56. Abbott Laboratories Company Information Table 57. Abbott Laboratories Business Overview Table 58. Abbott Laboratories Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Abbott Laboratories Biomedical Materials Product Portfolio Table 60. Abbott Laboratories Recent Development Table 61. Stryker Company Information Table 62. Stryker Business Overview Table 63. Stryker Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Stryker Biomedical Materials Product Portfolio Table 65. Stryker Recent Development Table 66. Boston Scientific Company Information Table 67. Boston Scientific Business Overview Table 68. Boston Scientific Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Boston Scientific Biomedical Materials Product Portfolio Table 70. Boston Scientific Recent Development Table 71. Smith+Nephew Company Information Table 72. Smith+Nephew Business Overview Table 73. Smith+Nephew Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Smith+Nephew Biomedical Materials Product Portfolio Table 75. Smith+Nephew Recent Development Table 76. B-Braun Company Information Table 77. B-Braun Business Overview Table 78. B-Braun Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. B-Braun Biomedical Materials Product Portfolio Table 80. B-Braun Recent Development Table 81. Straumann Company Information Table 82. Straumann Business Overview Table 83. Straumann Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Straumann Biomedical Materials Product Portfolio Table 85. Straumann Recent Development Table 86. Danaher Corporation Company Information Table 87. Danaher Corporation Business Overview Table 88. Danaher Corporation Biomedical Materials Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Danaher Corporation Biomedical Materials Product Portfolio Table 90. Danaher Corporation Recent Development Table 91. Dentsply Sirona Company Information Table 92. Dentsply Sirona Business Overview Table 93. Dentsply Sirona Biomedical Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Dentsply Sirona Biomedical Materials Product Portfolio Table 95. Dentsply Sirona Recent Development Table 96. Cook Medical Company Information Table 97. Cook Medical Business Overview Table 98. Cook Medical Biomedical Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Cook Medical Biomedical Materials Product Portfolio Table 100. Cook Medical Recent Development Table 101. Terumo Company Information Table 102. Terumo Business Overview Table 103. Terumo Biomedical Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Terumo Biomedical Materials Product Portfolio Table 105. Terumo Recent Development Table 106. MicroPort Company Information Table 107. MicroPort Business Overview Table 108. MicroPort Biomedical Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. MicroPort Biomedical Materials Product Portfolio Table 110. MicroPort Recent Development Table 111. Lepu Medical Company Information Table 112. Lepu Medical Business Overview Table 113. Lepu Medical Biomedical Materials Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lepu Medical Biomedical Materials Product Portfolio Table 115. Lepu Medical Recent Development Table 116. Research Programs/Design for This Report Table 117. Authors List of This Report Table 118. Secondary Sources Table 119. Primary Sources List of Figures Figure 1. Biomedical Materials Product Image Figure 2. Global Biomedical Materials Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biomedical Materials Market Size (2021-2032) & (US$ Million) Figure 4. Global Biomedical Materials Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Orthopaedic Image Figure 8. Cardiac Surgery Image Figure 9. Neurosurgery Image Figure 10. Plastic Surgery Image Figure 11. Other Image Figure 12. Global Biomedical Materials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Biomedical Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Biomedical Materials Sales Value Share by Type (2021-2032) Figure 15. Treatment Image Figure 16. Health and Beauty Image Figure 17. Global Biomedical Materials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Biomedical Materials Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Biomedical Materials Sales Value Share by Application (2021-2032) Figure 20. Global Biomedical Materials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Biomedical Materials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Biomedical Materials Sales Value (2021-2032) & (US$ Million) Figure 23. North America Biomedical Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Biomedical Materials Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Biomedical Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Biomedical Materials Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Biomedical Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Biomedical Materials Sales Value (2021-2032) & (US$ Million) Figure 29. South America Biomedical Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Biomedical Materials Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Biomedical Materials Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Biomedical Materials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Biomedical Materials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Biomedical Materials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Orthopaedic
  • Cardiac Surgery
  • Neurosurgery
  • Plastic Surgery
  • Other
Applications
  • Treatment
  • Health and Beauty
Companies covered
  • Johnson & Johnson
  • ZimmerBiomet
  • Medtronic
  • Abbott Laboratories
  • Stryker
  • Boston Scientific
  • Smith+Nephew
  • B-Braun
  • Straumann
  • Danaher Corporation
  • Dentsply Sirona
  • Cook Medical
  • Terumo
  • MicroPort
  • Lepu Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biomedical Materials Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biomedical Materials Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biomedical Materials Market Dynamics
  1. 2.1 Biomedical Materials Industry Trends
  2. 2.2 Biomedical Materials Industry Drivers
  3. 2.3 Biomedical Materials Industry Opportunities and Challenges
  4. 2.4 Biomedical Materials Industry Restraints
3 Biomedical Materials Market by Company
  1. 3.1 Global Biomedical Materials Company Revenue Ranking in 2025
  2. 3.2 Global Biomedical Materials Revenue by Company (2021-2026)
  3. 3.3 Global Biomedical Materials Company Ranking (2024-2026)
  4. 3.4 Global Biomedical Materials Company Manufacturing Base and Headquarters
  5. 3.5 Global Biomedical Materials Company Product Type and Application
  6. 3.6 Global Biomedical Materials Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biomedical Materials Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biomedical Materials Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biomedical Materials Market by Type
  1. 4.1 Biomedical Materials Type Introduction
  2. 4.1.1 Orthopaedic
  3. 4.1.2 Cardiac Surgery
  4. 4.1.3 Neurosurgery
  5. 4.1.4 Plastic Surgery
  6. 4.1.5 Other
  7. 4.2 Global Biomedical Materials Sales Value by Type
  8. 4.2.1 Global Biomedical Materials Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Biomedical Materials Sales Value by Type (2021-2032)
  10. 4.2.3 Global Biomedical Materials Sales Value Share by Type (2021-2032)
5 Biomedical Materials Market by Application
  1. 5.1 Biomedical Materials Application Introduction
  2. 5.1.1 Treatment
  3. 5.1.2 Health and Beauty
  4. 5.2 Global Biomedical Materials Sales Value by Application
  5. 5.2.1 Global Biomedical Materials Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Biomedical Materials Sales Value by Application (2021-2032)
  7. 5.2.3 Global Biomedical Materials Sales Value Share by Application (2021-2032)
6 Biomedical Materials Regional Value Analysis
  1. 6.1 Global Biomedical Materials Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biomedical Materials Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biomedical Materials Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biomedical Materials Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biomedical Materials Sales Value (2021-2032)
  7. 6.3.2 North America Biomedical Materials Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biomedical Materials Sales Value (2021-2032)
  10. 6.4.2 Europe Biomedical Materials Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biomedical Materials Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biomedical Materials Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biomedical Materials Sales Value (2021-2032)
  16. 6.6.2 South America Biomedical Materials Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biomedical Materials Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biomedical Materials Sales Value Share by Country, 2025 VS 2032
7 Biomedical Materials Country-level Value Analysis
  1. 7.1 Global Biomedical Materials Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biomedical Materials Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biomedical Materials Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biomedical Materials Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biomedical Materials Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biomedical Materials Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biomedical Materials Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biomedical Materials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biomedical Materials Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biomedical Materials Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biomedical Materials Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biomedical Materials Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biomedical Materials Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biomedical Materials Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biomedical Materials Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biomedical Materials Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biomedical Materials Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biomedical Materials Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biomedical Materials Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biomedical Materials Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biomedical Materials Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biomedical Materials Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biomedical Materials Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biomedical Materials Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biomedical Materials Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biomedical Materials Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biomedical Materials Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biomedical Materials Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biomedical Materials Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biomedical Materials Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biomedical Materials Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biomedical Materials Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biomedical Materials Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biomedical Materials Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biomedical Materials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Johnson & Johnson
  2. 8.1.1 Johnson & Johnson Company Information
  3. 8.1.2 Johnson & Johnson Business Overview
  4. 8.1.3 Johnson & Johnson Biomedical Materials Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Johnson & Johnson Biomedical Materials Product Portfolio
  6. 8.1.5 Johnson & Johnson Recent Developments
  7. 8.2 ZimmerBiomet
  8. 8.2.1 ZimmerBiomet Company Information
  9. 8.2.2 ZimmerBiomet Business Overview
  10. 8.2.3 ZimmerBiomet Biomedical Materials Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ZimmerBiomet Biomedical Materials Product Portfolio
  12. 8.2.5 ZimmerBiomet Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Biomedical Materials Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Biomedical Materials Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
  19. 8.4 Abbott Laboratories
  20. 8.4.1 Abbott Laboratories Company Information
  21. 8.4.2 Abbott Laboratories Business Overview
  22. 8.4.3 Abbott Laboratories Biomedical Materials Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Abbott Laboratories Biomedical Materials Product Portfolio
  24. 8.4.5 Abbott Laboratories Recent Developments
  25. 8.5 Stryker
  26. 8.5.1 Stryker Company Information
  27. 8.5.2 Stryker Business Overview
  28. 8.5.3 Stryker Biomedical Materials Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Stryker Biomedical Materials Product Portfolio
  30. 8.5.5 Stryker Recent Developments
  31. 8.6 Boston Scientific
  32. 8.6.1 Boston Scientific Company Information
  33. 8.6.2 Boston Scientific Business Overview
  34. 8.6.3 Boston Scientific Biomedical Materials Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Boston Scientific Biomedical Materials Product Portfolio
  36. 8.6.5 Boston Scientific Recent Developments
  37. 8.7 Smith+Nephew
  38. 8.7.1 Smith+Nephew Company Information
  39. 8.7.2 Smith+Nephew Business Overview
  40. 8.7.3 Smith+Nephew Biomedical Materials Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Smith+Nephew Biomedical Materials Product Portfolio
  42. 8.7.5 Smith+Nephew Recent Developments
  43. 8.8 B-Braun
  44. 8.8.1 B-Braun Company Information
  45. 8.8.2 B-Braun Business Overview
  46. 8.8.3 B-Braun Biomedical Materials Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B-Braun Biomedical Materials Product Portfolio
  48. 8.8.5 B-Braun Recent Developments
  49. 8.9 Straumann
  50. 8.9.1 Straumann Company Information
  51. 8.9.2 Straumann Business Overview
  52. 8.9.3 Straumann Biomedical Materials Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Straumann Biomedical Materials Product Portfolio
  54. 8.9.5 Straumann Recent Developments
  55. 8.10 Danaher Corporation
  56. 8.10.1 Danaher Corporation Company Information
  57. 8.10.2 Danaher Corporation Business Overview
  58. 8.10.3 Danaher Corporation Biomedical Materials Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Danaher Corporation Biomedical Materials Product Portfolio
  60. 8.10.5 Danaher Corporation Recent Developments
  61. 8.11 Dentsply Sirona
  62. 8.11.1 Dentsply Sirona Company Information
  63. 8.11.2 Dentsply Sirona Business Overview
  64. 8.11.3 Dentsply Sirona Biomedical Materials Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dentsply Sirona Biomedical Materials Product Portfolio
  66. 8.11.5 Dentsply Sirona Recent Developments
  67. 8.12 Cook Medical
  68. 8.12.1 Cook Medical Company Information
  69. 8.12.2 Cook Medical Business Overview
  70. 8.12.3 Cook Medical Biomedical Materials Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cook Medical Biomedical Materials Product Portfolio
  72. 8.12.5 Cook Medical Recent Developments
  73. 8.13 Terumo
  74. 8.13.1 Terumo Company Information
  75. 8.13.2 Terumo Business Overview
  76. 8.13.3 Terumo Biomedical Materials Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Terumo Biomedical Materials Product Portfolio
  78. 8.13.5 Terumo Recent Developments
  79. 8.14 MicroPort
  80. 8.14.1 MicroPort Company Information
  81. 8.14.2 MicroPort Business Overview
  82. 8.14.3 MicroPort Biomedical Materials Revenue and Gross Margin (2021-2026)
  83. 8.14.4 MicroPort Biomedical Materials Product Portfolio
  84. 8.14.5 MicroPort Recent Developments
  85. 8.15 Lepu Medical
  86. 8.15.1 Lepu Medical Company Information
  87. 8.15.2 Lepu Medical Business Overview
  88. 8.15.3 Lepu Medical Biomedical Materials Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Lepu Medical Biomedical Materials Product Portfolio
  90. 8.15.5 Lepu Medical Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst